Oncoinvent ASA (KLDVK) — Cash Flow Quality Index
Latest as of December 2023:
-0.56x
Oncoinvent ASA (KLDVK) has a Cash Flow Quality Index of -0.56x as of December 2023. Operating cash flow of Nkr-40.23 Million is below net income of Nkr72.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Oncoinvent ASA to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.56x
Operating CF / Net Income
Operating Cash Flow
Nkr-40.23 Million
NOK
Net Income
Nkr72.41 Million
NOK
Data as of
Dec 2023
Most recent filing
Oncoinvent ASA Cash Flow Quality Index (2021–2023)
Historical Cash Flow Quality Index for Oncoinvent ASA across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see KLDVK cash flow conversion.
Annual Cash Flow Quality Index for Oncoinvent ASA (2021–2023)
Year-by-year earnings quality comparison for Oncoinvent ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.56x | Nkr-40.23 Million | Nkr72.41 Million | ▼ -949.1% |
| 2021 | 0.07x | Nkr130.66K | Nkr2.00 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.